Takeda Pharmaceutical Company Limited Provisions
Takeda Pharmaceutical Company Limited (TAK) had Provisions of JPY 568.32 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:Provisions · last filed 2025-06-25
- 2025-03-31: Provisions 568.32B JPY.
- 2024-03-31: Provisions 538.79B JPY.
- 2023-03-31: Provisions 564.33B JPY.
- 2022-03-31: Provisions 495.70B JPY.
| Period end | Provisions | Provisions as first filed |
|---|---|---|
| 2025-03-31 | 568.32B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 538.79B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 564.33B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 495.70B JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 510.03B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | 442.85B JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | 412.29B JPY 20-F · filed 2021-06-29 | 428.10B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 160.82B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | 173.90B JPY 20-F · filed 2019-06-27 |